Chu Yu-Waye's Form 4 filing
Fate Therapeutics Inc (FATE) · filed Apr 19, 2023
- Accession no.
- 0001209191-23-024820
- Filed
- Apr 19, 2023
- Trade date
- Apr 18, 2023
- Filing delay
- 1 day
- Rule 10b5-1 plan
- Checked
This filing lists 2 non-derivative transactions and 0 derivative transactions. Open-market sales total $16.6K. It was filed 1 day after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| Chu Yu-WayeCIK 0001854586 | Officer (Chief Medical Officer) |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Apr 18, 2023 | Common Stock | SSaleDisposed | −215 | $6.52 | −$1,401.8 | 142,993 | Direct | |
| Apr 18, 2023 | Common Stock | SSaleDisposed | −2,317 | $6.58 | −$15,245.86 | 140,676 | Direct |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.